Compare PEPG & HCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PEPG | HCKT |
|---|---|---|
| Founded | 2018 | 1991 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Professional Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 440.0M | 392.0M |
| IPO Year | 2022 | 1998 |
| Metric | PEPG | HCKT |
|---|---|---|
| Price | $6.72 | $14.09 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 6 | 1 |
| Target Price | $11.67 | ★ $17.00 |
| AVG Volume (30 Days) | ★ 597.7K | 313.8K |
| Earning Date | 01-01-0001 | 05-19-2026 |
| Dividend Yield | N/A | ★ 3.46% |
| EPS Growth | ★ 13.64 | N/A |
| EPS | N/A | ★ 0.46 |
| Revenue | N/A | ★ $285,862,000.00 |
| Revenue This Year | N/A | $2.55 |
| Revenue Next Year | N/A | $5.07 |
| P/E Ratio | ★ N/A | $30.27 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.89 | $12.76 |
| 52 Week High | $7.80 | $29.65 |
| Indicator | PEPG | HCKT |
|---|---|---|
| Relative Strength Index (RSI) | 59.75 | 38.31 |
| Support Level | $4.36 | $12.76 |
| Resistance Level | $6.81 | $21.13 |
| Average True Range (ATR) | 0.60 | 0.68 |
| MACD | 0.04 | 0.15 |
| Stochastic Oscillator | 70.57 | 52.61 |
PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics to transform the treatment of severe neuromuscular and neurologic diseases. The company has developed its Enhanced Delivery Oligonucleotide platform to improve the uptake and activity of conjugated oligonucleotide therapeutics. Its EDO peptides are engineered to optimize tissue penetration, cellular uptake, and nuclear delivery, and in preclinical studies, it is observed their ability to transport oligonucleotides into a broad range of target tissues, including smooth, skeletal, and cardiac muscle and the central nervous system. Its pipeline products are; PGN-EDO51, PGN-EDODM1, and others including PGN-EDO53 and PGN-EDO45.
The Hackett Group Inc is an IP platform-based Generative Artificial Intelligence (Gen AI) strategic consulting and executive advisory digital transformation firm. The Hackett Group provides dedicated expertise in Gen AI-enabled enterprise transformation services across the front, mid and back office areas, including its highly recognized Oracle, SAP, OneStream and Coupa implementation offerings. It operates in three segments Oracle Solutions, SAP Solutions, and Global S&BT. It generates the majority of its revenue from the Global S&BT segment in the United States.